July 30, 2010 (Vienna, Austria) — Although initiation of highly active antiretroviral therapy (HAART) against HIV is associated with a lower risk for progression to AIDS, and a lower risk for ...

Immunocompromised populations develop a lower immunogenic response to COVID-19 vaccines, leaving them at a higher risk of severe disease, hospitalization, and death. Patients with HIV who have low ...

Jan. 20, 2005 -- The U.S. Food and Drug Administration (FDA) has informed healthcare professionals and patients via a public health advisory of the risk of hepatotoxicity associated with initiating ...

This is a preview. Log in through your library . Abstract Background. The extent and duration of long-term recovery of CD4 count, CD4 percentage (CD4%), and CD4/CD8 ratio after initiation of ...

Background. It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)–monoinfected patients with suppressed viral loads and CD4 cell counts >300 cell/μL could ...

ALD518, a humanized anti-IL-6 antibody, treats anemia in patients with advanced non-small cell lung cancer (NSCLC): Results of a phase II, randomized, double-blind, placebo-controlled trial.